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Abstract  
Nematode Strongyloides stercoralis, outside tropics and subtropics present in small endemic 
foci, can cause an infection after direct skin contact with contaminated soil containing infective 
filariform larvae and, rarely, after intimate interhuman contact or after transplantation of an 
infected solid organ. Following skin penetration, migration, and maturation through several 
stages, a small number of invasive filariform larvae can develop anew in the gut lumen, 
perpetuating new cycles of penetration, tissue-migration, and multiplication, without leaving 
the host. In a state of immunosuppression, autoinfection can progress to life-threatening 
hyperinfection and/or infection disseminated through virtually any organ.  
In developed countries, the most frequently recognized risk for severe hyperinfection is 
corticosteroid therapy, but it has been also described in malnourished, alcoholic, cancer, and 
transplant patients. Due to the frequent need for immunosuppressive therapy, patients 
suffering from inflammatory bowel disease (IBD) are susceptible to developing overwhelming 
strongyloidiasis. Strongyloidiasis can be easily overlooked in clinical settings and in many 
European regions there is poor insight into the epidemiological burden of this disease. 
We present a case of overwhelming strongyloidiasis which triggered three successive 
episodes of sepsis caused by gut flora in a young patient suffering from stenotic form of Crohnʹs 
disease.  S. stercoralis hyperinfection occurred in the corticosteroid-free period, shortly after 
the terminal ileum resection which was probably the trigger for the overwhelming course. The 
patient was successfully treated with 10-day albendazole therapy.  
Disease pathogenesis in our patient is discussed, as well as the epidemiological features of 
strongyloidiasis in Europe, therapeutic options, and possible diagnostic strategies in patients 
affected by IBD. 
Key words: Crohnʹs Disease, overwhelming strongyloidiasis, hyperinfection, eosinophilia, 
sepsis, immunosuppression, ileum resection 
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Abstract in German 
Strongyloides stercoralis, der Zwergfadenwurm, der außerhalb der Tropen und Subtropen in 
kleinen endemischen Regionen vorkommt, kann nach direktem Kontakt der Haut mit 
kontaminiertem Boden,- der die infektiösen, filariformen Larven enthält oder selten durch 
intimen zwischenmenschlichen Kontakt oder Transplantation eines infizierten Organs,- eine 
Infektion verursachen. Nach der Hautpenetration, Migration und Reifung über mehrere Stadien 
kann sich eine kleine Anzahl von invasiven, filariformen Larven im Darmlumen entwickeln und 
weiter einen neuen Zyklus der Gewebseinwanderung und Vermehrung fortsetzen, ohne den 
Wirt zu verlassen. Im Stadium einer Immunsuppression kann sich eine solche 
Selbstansteckung in eine lebensbedrohliche hyper/disseminierte Infektion entwickeln. 
In hochentwickelten Ländern stellt die Therapie mit Kortikosteroiden das häufigste bekannte 
Risiko für eine ausgeprägte Hyperinfektion dar. Aber sie wurde auch bei unterernährten, 
alkoholabhängigen und Krebspatienten, sowie bei transplantierten Patienten beschrieben. 
Wegen der oftmaligen Notwendigkeit einer immunsuppressiven Therapie bei Patienten mit 
einer chronisch-entzündlichen Darmerkrankung (CED) sind diese anfällig für die Entwicklung 
einer verheerenden Strongyloidiasis. In vielen europäischen Regionen besteht wenig 
Verständnis für die Epidemiologie dieser Erkrankung und kann daher im klinischen Alltag leicht 
übersehen werden. 
Wir stellen den Fall einer schweren Strongyloidiasis-Hyperinfektion bei einem jungen 
Patienten mit einer stenosierenden Form eines Morbus Crohn vor, bei dem durch die 
Darmflora drei aufeinanderfolgende Schübe einer Sepsis ausgelöst wurden. Die 
Hyperinfektion mit S. stercoralis hat sich in einer kortikoidfreien Zeit entwickelt, kurz nach der 
Resektion des terminalen Ileums, die vermutlich der Auslöser des verheerenden Verlaufes 
war. Der Patient wurde erfolgreich mit einer 10-tägigen Albendazol-Therapie geheilt. 
Wir haben die Pathogenese der Erkrankung bei unserem Patienten besprochen und auch die 
epidemiologischen Besonderheiten der Strongyloidiasis in Europa, die Therapiemöglichkeiten 
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und die möglichen Diagnosestrategien bei Patienten mit CED. 
Schlüsselwörter: Morbus Crohn, Strongyloidiasis, Hyperinfektion, Eosinophilie, Sepsis, 
Immunsuppression, Darmresektion  
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Case report 
Due to acute exacerbation of chronic obstructive ileus in a 37-year old male patient with 
stenotic and fistulizing form of previously therapeutically neglected Crohnʹs disease, a 
resection of the terminal ileum was performed in September 2015.  
The patient, who lived in sanitated urban conditions in continental Croatia, was diagnosed with 
Crohnʹs disease at the age of 25. It progressed to an advanced stenotic and fistulizing form by 
the age of 35 despite a lingering, but unsettled, mesalazine and methylprednisolone therapy. 
The disease was also complicated by an ischemic cerebellar stroke at the age of 36, and by 
arterial occlusions of the lower extremities, which led to consecutive bilateral transtibial leg 
amputations in March and April 2015. During May and July 2015, the patient was institutionally 
rehabilitated with the aim of adopting prosthetic legs, and he was continuously confined to an 
indoor home and hospital environment. 
Preoperative imaging evaluation revealed multiple ileal stenoses, up to 2 mm, prestenotic 
dilations, up to 7 cm, with radiological signs of chronic ileus accompanied by several 
enteroenteral/colic fistulas, which enabled normal enteral passage. 
Esophagogastroduodenoscopy (EGD) with pathohistological diagnosis (PHD) of gastric and 
duodenal mucosa samples yielded normal findings, and colonoscopy revealed stenotic valvula 
Bauchini. 
At hospital admission, the patient with legs amputated was symptom-free and afebrile, but 
extremely malnourished. Reported laboratory findings were: serum protein level 34 g/L, 
albumin 13.3 g/L, RBCs 2.73x1012/L, Hb 111 g/L, MCV 105.9 fL, Tr 550x109/L, L 14.2x109/L 
with 1% eosinophils (EO) in differential count. Beside slightly decreased serum iron, calcium, 
phosphorus and magnesium levels, as well as C-reactive protein (CRP) of 8.9 mg/L, other 
routinely performed laboratory tests were unremarkable. Corticosteroid therapy 
(methylprednisolone 12 mg/day), was discontinued and intensive combined parenteral and 
enteral nutrition was introduced.  
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On the 20th in-hospital day, clinical and radiological signs of complete enteral passage 
obstruction urged a surgical treatment. A resection of 63 cm of terminal ileum, cecum and 
appendix was performed with strictureplasty and formation of unipolar stoma. 
Postoperative fever with an increase of CRP to 196.2 mg/L, but without bacterial isolates, was 
empirically treated with a combination of meropenem, ciprofloxacin, and metronidazole, which 
ultimately led to resolution.  
On the 6th postoperative day, clinical and MSCT signs of diffuse peritonitis developed. After 
relaparotomy, lavage, and drainage, many EO were seen in ascetic fluid. Blood, urine, and 
ascites cultures remained sterile and empirical therapy with meropenem was continued. 
However, during 6 weeks following peritonitis, the patientʹs condition deteriorated. Peripheral 
blood eosinophilia developed and reached continuously high levels, up to 6480 EO/µl. The 
almost continuously febrile patient had to be subjected to targeted antibiotic/antifungal therapy 
thrice, due to serial bouts of severe, presumably enteral sepsis, with Enterococcus faecium, 
Candida albicans and Escherichia coli proven by blood cultures, respectively.    
In the critically ill, severely hypoalbuminemic patient with continuous weight loss, an EGD was 
performed after 6 weeks of clinical deterioration. PHD of gastric and duodenal bioptic samples 
revealed rich eosinophilic infiltration of lamina propria, and worm-like structures matching 
morphological characteristics of Strongyloides stercoralis (Figure 1). Blood serology 
(qualitative ELISA test # 9450 Strongyloïdes ratti, Bordier, Switzerland) was positive for S. 
stercoralis, but stool samples remained negative thrice for ova and parasites, by flotation 
methods and staining, microscopy of direct wet smears, and agar plate culture. 
After initiation of a 10-day albendazole therapy in a dose of 15 mg/kg/day, the patient´s 
condition rapidly improved; symptoms resolved, and eosinophilia receded. One month later, 
ileostomy occlusion was performed and the patient was discharged without 
immunosuppressive therapy.  
On follow-up visit, three months after albendazole therapy, the patient´s stool samples 
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remained negative for parasites, and peripheral blood eosinophilia resolved completely. The 
symptom-free patient fully recovered, but further colonoscopy revealed a relapse of Crohnʹs 
disease in neoterminal ileum. Because of the patient´s intolerance to cytostatics, infliximab 
therapy was introduced in May 2017, which was followed neither by clinical nor laboratory 
signs of strongyloidiasis reactivation. Unfortunately, the patient has not showed up for further 
parasitological controls. 
 
Discussion  
Although multiple predisposing factors for reactivation of chronic strongyloidiasis were present 
in our patient, namely the four weeks earlier discontinued corticosteroid therapy, severe 
malnutrition, and chronically disturbed gut passage, we believe, based on clinical symptoms 
sequence and laboratory signs, that ileal resection triggered the overwhelming strongyloidiasis 
in our patient. To our knowledge, such a case has not been previously described in literature. 
Impaired gut motility has been recognized as one of the predisposing factors for reactivation 
of strongyloidiasis. Inversely, cases were described, where an overwhelming strongyloidiasis 
precipitated gut obstruction - in cases of acute primary hyperinfection, and those involving a 
reactivation of chronic infection in immunocompromised host [1-3].  
Although usually penetrating colonic mucosa and perianal skin, the massive penetration of 
gastric and duodenal mucosa has also been described in patients with ulcerative colitis [4,5]. 
Normal EGD and PHD findings during preoperative evaluation suggest our patient being in an 
asymptomatic steady state with a low parasite burden. 
Translocation of bacteria due to transmural migration of parasitic larvae has been proposed as 
a mechanism of death in immunocompromised patients [6]. Among 27 solid organ transplant 
recipients with donor-derived strongyloidiasis, the presence of sepsis was a predictor of 
mortality, as it was seen in all 9 patients who died (100.0%) and in 4 patients who survived 
(23.5%; P < .001) [7]. Despite targeted treatment of three septic episodes, each caused by 
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enteric flora, definitive improvement in our patient was achieved eventually by antiparasitic 
treatment, which supports the importance of transmural larval migration in their pathogenesis. 
The prevalence and incidence of S. stercoralis infection in Croatia is unknown. Even in 
endemic regions, strongyloidiasis is one of the most overlooked helminthiasis among the 
neglected tropical diseases. Scarce studies regarding areas in European countries reveal 
strongyloidiasis prevalence in hospital settings: Italy 1.8%, Spain 1.9, Austria 5.2%, France 
31.1%, Romania 48.8%; in community-based studies: Spain 14.8%, United Kingdom 12.7%, 
northern Italy 1%; and among refugees and immigrants: Sweden 1.0%, Italy 3.3%, Spain 4.2%, 
and France 5.6% [8,9]. In Germany, S. stercoralis infection is recognized as a parasitic 
professional disease in miners [10].  In Europe, there have been sporadic cases of reactivated 
strongyloidiasis in immunocompromised patients, reported from Belgium, Netherlands, Spain 
and Italy [11-14].   
Peroral ivermectin is the first-line therapy for severe, overwhelming strongyloidiasis, with a 
reported eradication rate of approximately 80% [15], albendazole being the second-line 
therapy, due to its reported failure rate of up to 50% [13]. In comparison to ivermectin, its 
absorption from gastrointestinal tract is poorer and half-life is shorter (8-12 h vs. 16-28 h, 
respectively) [16]. However, unlike ivermectin, it does cross the blood-brain barrier, which 
makes it suitable for treating cerebral form of strongyloidiasis, and it binds less to serum 
proteins (70% vs. 93%, respectively) [16]. We believe that profound serum hypoproteinemia 
can enhance the efficacy of albendazole by increasing serum albendazole concentration which 
might have contributed to a rapid clinical cure with a single 10-day course in our patient, who 
was treated with albendazole because of its immediate availability.  
Preventive parasitological examination of stool samples before starting immunosuppressive 
therapy, especially corticosteroids, in patients with IBD, has been proposed in the early 1980s 
[17]. This was followed by the recommendation for serological screening in patients from 
endemic areas, and those with unspecific GI symptoms or eosinophilia, before solid organ or 
hematopoetic transplantation [7,18,19].    
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Absence of eosinophilia in some symptomatic cases [20], and low sensitivity of parasitic stool 
sample examinations in patients with strongyloidiasis, not exceeding 46% even after 3 stool 
examinations, suggest the use of serological testing for diagnostics in symptomatic patients, 
whereby the sensitivity by ELISA can exceed 95% [21]. In patients with impaired gut passage 
and suspected severe strongyloidiasis, the examination of duodenal aspirate or a biopsy 
sample, in which the yield can be very high during hyperinfection, is a more appropriate direct 
diagnostic test.  
We can conclude that gut resection should be considered as a potential trigger for 
overwhelming strongyloidiasis in chronically infected patients. Besides several parasitic stool 
examinations, we suggest serological screening in patients with IBD who might be exposed 
and in whom abdominal surgical treatment is planned. However, when eosinophilia and/or 
clinical symptoms develop in a postoperative period, an early EGD procedure with analysis of 
duodenal aspirate and biopsies could contribute to a rapid diagnosis in those patients.  
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Figure 1. Bioptic sample of the duodenum with Strongyloides larvae visualized close to the 
mucosal surface and rich eosinophilic infiltration of lamina propria 
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